Home | About the eMC | Help | Mobile

eMC - trusted, up to date and comprehensive information about medicines

Search medicine/company name only

Search full document

Medicine name A-Z | Active ingredient A-Z | Pharmaceutical company A-Z | Latest medicine updates | Yellow card report

THE BOOTS COMPANY PLC
1 Thane Road West, Beeston, Nottingham, NG2 3AA Telephone: +44 (0)1159 595 165 Fax: +44 (0)1159 592 565 Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?

Summary of Product Characteristics last updated on the eMC: 05/12/2011

SPC	Boots Hayfever Relief Eye Drops

Table of Contents

1. NAME OF THE MEDICINAL PRODUCT
2. QUALITATIVE AND QUANTITATIVE COMPOSITION
3. PHARMACEUTICAL FORM
4. CLINICAL PARTICULARS
4.1 Therapeutic indications
4.2 Posology and method of administration
4.3 Contraindications
4.4 Special warnings and precautions for use
4.5 Interaction with other medicinal products and other forms of interaction
4.6 Pregnancy and lactation
4.7 Effects on ability to drive and use machines
4.8 Undesirable effects
4.9 Overdose
5. PHARMACOLOGICAL PROPERTIES
5.1 Pharmacodynamic properties
5.2 Pharmacokinetic properties
5.3 Preclinical safety data
6. PHARMACEUTICAL PARTICULARS
6.1 List of excipients
6.2 Incompatibilities
6.3 Shelf life
6.4 Special precautions for storage
6.5 Nature and contents of container
6.6 Special precautions for disposal and other handling
7. MARKETING AUTHORISATION HOLDER
8. MARKETING AUTHORISATION NUMBER(S)
9. DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION
10. DATE OF REVISION OF THE TEXT

Go to top of the page

1. NAME OF THE MEDICINAL PRODUCT

Sodium Cromoglicate Eye Drops 2% w/v

Pollenase Allergy Eye Drops

Lloyds Pharmacy Allergy Relief Eye Drops

Vantage Allergy Eye Drops

Boots Hayfever Relief Eye Drops

Go to top of the page

2. QUALITATIVE AND QUANTITATIVE COMPOSITION

Sodium cromoglicate BP (equivalent to anhydrous sodium cromoglicate)

Go to top of the page

3. PHARMACEUTICAL FORM

Eye drops

Go to top of the page

4. CLINICAL PARTICULARS

Go to top of the page

4.1 Therapeutic indications

A) 13.5m1 packs:	(POM): For the relief and treatment of acute allergic conjunctivitis such as hayfever, chronic allergic conjunctivitis and vernal kerato conjunctivitis.
B) 5m1 and 10ml packs:	(P): For the treatment of Hayfever

Go to top of the page

4.2 Posology and method of administration

Adults and Children:

One or two drops to be administered into each eye four times daily, or as prescribed by the doctor.

Elderly:

There is no evidence to suggest that dosage alteration is required for elderly patients.

Go to top of the page

4.3 Contraindications

Known hypersensitivity to any ingredient, including sodium cromoglicate, benzalkonium chloride and disodium edetate.

Go to top of the page

4.4 Special warnings and precautions for use

Soft contact lenses should not be worn during treatment with Sodium Cromoglicate Eye Drops.

Go to top of the page

4.5 Interaction with other medicinal products and other forms of interaction

None known.

Go to top of the page

4.6 Pregnancy and lactation

Cumulative experience with sodium cromoglicate suggests that it has no adverse effects on foetal development. However, as with all medicines, caution should be exercised during pregnancy, and it should be used in pregnancy only when there is a clear need.

Go to top of the page

4.7 Effects on ability to drive and use machines

Instillation may cause transient blurring of vision. Do not drive or operate machinery if affected.

Go to top of the page

4.8 Undesirable effects

Transient stinging and blurring of vision may occur. Other symptoms of local irritation have been reported rarely.

Go to top of the page

4.9 Overdose

Overdosage is very unlikely. In the event of accidental ingestion, symptomatic treatment is recommended.

Go to top of the page

5. PHARMACOLOGICAL PROPERTIES

Go to top of the page